| 000 | 01820 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517094821.0 | ||
| 264 | 0 | _c20170330 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1521-7035 | ||
| 024 | 7 |
_a10.1016/j.clim.2016.05.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuijts, Charlotte M | |
| 245 | 0 | 0 |
_aDifferential effects of inhibitors of the PI3K/mTOR pathway on the expansion and functionality of regulatory T cells. _h[electronic resource] |
| 260 |
_bClinical immunology (Orlando, Fla.) _c07 2016 |
||
| 300 |
_a47-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAminopyridines _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCytokines _ximmunology |
| 650 | 0 | 4 |
_aEverolimus _xpharmacology |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 |
_aMorpholines _xpharmacology |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
| 650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
| 650 | 0 | 4 |
_aQuinolines _xpharmacology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSirolimus _xpharmacology |
| 650 | 0 | 4 |
_aT-Lymphocytes, Regulatory _xcytology |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
| 700 | 1 | _aSantegoets, Saskia J | |
| 700 | 1 | _aQuiles Del Rey, Maria | |
| 700 | 1 | _ade Haas, Richard R | |
| 700 | 1 | _aVerheul, Henk M | |
| 700 | 1 | _ade Gruijl, Tanja D | |
| 700 | 1 | _avan der Vliet, Hans J | |
| 773 | 0 |
_tClinical immunology (Orlando, Fla.) _gvol. 168 _gp. 47-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clim.2016.05.005 _zAvailable from publisher's website |
| 999 |
_c26029537 _d26029537 |
||